Article thumbnail

Cord Blood-Derived Hematopoietic Stem/Progenitor Cells: Current Challenges in Engraftment, Infection, and Ex Vivo Expansion

By Katsuhiro Kita, Jong O. Lee, Celeste C. Finnerty and David N. Herndon


Umbilical cord blood has served as an alternative to bone marrow for hematopoietic transplantation since the late 1980s. Numerous clinical studies have proven the efficacy of umbilical cord blood. Moreover, the possible immaturity of cells in umbilical cord blood gives more options to recipients with HLA mismatch and allows for the use of umbilical cord blood from unrelated donors. However, morbidity and mortality rates associated with hematopoietic malignancies still remain relatively high, even after cord blood transplantation. Infections and relapse are the major causes of death after cord blood transplantation in patients with hematopoietic diseases. Recently, new strategies have been introduced to improve these major problems. Establishing better protocols for simple isolation of primitive cells and ex vivo expansion will also be very important. In this short review, we discuss several recent promising findings related to the technical improvement of cord blood transplantation

Topics: Review Article
Publisher: SAGE-Hindawi Access to Research
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1995). A .B a l d u z z i ,T .G o o l e y ,C .A n a s e t t ie ta l . ,“ U n r e l a t e dd o n o r marrow transplantation in children,” Blood,v o l .8 6 ,n o .8 ,p p .
  2. (2000). A .R .M i g l i a c c i o ,J .W .A d a m s o n ,C .E .S t e v e n s ,N .L .D o b r i l a
  3. (1993). a b u t t i ,F .T i m e u s ,U .R a m e n g h ie ta l . ,“ E x p a n s i o no fc o r d blood progenitors and use for hemopoietic reconstitution,”
  4. (2009). A functional screen to identify vovel effectors of hematopoietic stem cell activity,”
  5. a k a h a t aa n dM .O g a w a ,“ H e m o p o i e t i cc o l o n y - f o r m i n g cells in umbilical cord blood with extensive capability to generate mono-andmultipotential hemopoieticprogenitors,”
  6. (1995). Allogeneic sibling umbilical-cordblood transplantation in children with malignant and nonmalignant disease,”
  7. (1993). Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program,” The New England
  8. (1993). andP.M.Lansdorp,“Expression ofThy-1 onhumanhematopoieticprogenitor cells,”
  9. (2010). Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells,”
  10. (2001). B a r k e r ,S .M .D a v i e s
  11. (1997). B r i d d e l l ,B .P .K e r n ,K .L .Z i l m ,G .B .S t o n e y ,a n dI .K . McNiece, “Purification of CD34+ cells is essential for optimal ex vivo expansion of umbilical cord blood cells,”
  12. (1996). Barber et al.,“Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity,”
  13. (1999). Bioreactors for haematopoietic cell culture,”
  14. (1997). Boyer-Chammardet al.,“Outcome of cord-blood transplantation from related and unrelated donors.
  15. (2002). Cell surface peptidase CD26/dipeptidylpeptidase IVregulates CXCL12/stromal cell-derived factor-1α-mediated chemotaxis of human cord blood CD34+ progenitor cells,”
  16. (1981). Characterization of hemopoietic stem cells (CFUc)
  17. (2009). Clinical scale ex vivo manufacture of neutrophils from hematopoietic progenitor cells,”
  18. (2004). Cord blood (CB) stem cells for wound repair: preliminary report of 2 cases,”
  19. (1999). Dependence of human stem cell engraftment and repopulation
  20. (2010). Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation,”
  21. (2005). Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells,”
  22. (1997). Dye efflux studies suggestthathematopoieticstemcells expressinglowor undetectable levels of CD34 antigen exist in multiple species,”
  23. (2002). Early infections in adult patients undergoing unrelated donor cord blood transplantation,”
  24. (1996). Ebihara et al., “Analysis on interleukin 6 receptor and gp130 expressions and proliferative capability ofhumanCD34+ cells,”
  25. (1994). Effects of recombinant human Steel factor (c-kit ligand) on early cord blood hematopoietic precursors,”
  26. (1998). Effects of thrombopoietin on the proliferation and differentiation of primitive and mature haemopoietic progenitor cells in cord blood,”
  27. (2006). Ex vivo expansion ofhematopoieticstem cells derived from umbilicalcord blood in rotating wall vessel,”
  28. (1991). Expression and function of c-kit in hemopoietic progenitor cells,”
  29. (1992). Further phenotypic characterization and isolationofhumanhematopoieticprogenitor cells using a monoclonalantibody to the c-kit receptor,”
  30. (1995). gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells,”
  31. (2002). h i s h i ,B .V a r n u m - F i n n e y ,a n dI .D .B e r n s t e i n ,“ D e l t a -1 enhances marrow and thymus repopulating ability of human CD34+CD38− cord blood cells,”
  32. (1978). Haematopoietic stem cells (CFUc) in human cord blood,”
  33. (1989). Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLAidentical sibling,” The New England
  34. (2001). Hematopoietic stem cells can be
  35. (1998). Human cord bloodderived primitive progenitors are enriched in CD34+c-kit -cells: correlation between long-term culture-initiating cells and telomerase expression,”
  36. (1997). Human umbilicalcord bloodmyeloidprogenitorcells arerelatively chemoresistant: a potential model for autologous transplantations in HIV-infected newborns,”American
  37. (1999). im,Y .F ujiki,T .F ukushima,H.Ema,A.Shibu y a,andH. Nakauchi, “Comparison of hematopoietic activities of human bone marrow and umbilical cord blood CD34 positive and negative cells,”
  38. (1998). In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment,” Blood,v o l .9 1 ,n o .1 ,p p .
  39. (2007). Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice,”
  40. (2001). Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of SCID repopulating cells,”
  41. (2000). Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions
  42. (1996). K r a u s e ,M .J .F a c k l e r ,C .I .C i v i n ,a n dW
  43. (2001). Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family,”
  44. (2001). L a u g h l i n ,J .B a r k e r ,B .B a m b a c he ta l . ,“ H e m a t o p o i e t i c engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors,” The New England
  45. (2001). Long-term expansion and maintenance of cord blood haematopoietic stem cells using thrombopoietin, Flt3-ligand, interleukin (IL)-6 and IL11 in a serum-free and stroma-free culture system,”
  46. (1996). Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoieticstem cell,”
  47. (2000). M c K e n n a ,K .L .S t o c k i n g ,R .E .M i l l e re ta l . ,“ M i c e lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells,”
  48. (1995). M c K e n n a ,P .D eV r i e s ,K .B r a s e l ,S .D .L y m a n ,a n dD . E. Williams, “Effect of flt3 ligand on the ex vivo expansion of humanCD34+ hematopoieticprogenitorcells,”
  49. (1994). M i l n e r ,R .K o p a n ,D .I .K .M a r t i n ,a n dI .D .B e r n s t e i n , “A human homologue of the Drosophila developmental gene, Notch, is expressed in CD34+ hematopoietic precursors,”
  50. (2004). Modulation of hematopoietic stem cell homing and engraftment by CD26,”
  51. (2003). Multiparametric analysis of immature cell populations in umbilical cord blood and bone marrow,”
  52. (2010). Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution,”
  53. (1998). o a r e s ,N .J .B o r t h w i c k ,M .K .M a i n i ,G .J a n o s s y
  54. (1997). o n g e n g ,R .A .K r a n c e ,L .C .B o w m a ne ta l . ,“ O u t c o m e s of transplantation with matched-sibling and unrelated-donor bonemarrowinchildren withleukaemia,”Lancet,vol.350,no. 9080,
  55. (1996). onemura,H.K u,F .H iray ama,L.M.Souza,andM.Oga wa, “Interleukin 3 or interleukin 1 abrogates the reconstituting abilityofhematopoieticstem cells,”Proceedings of the
  56. (2006). Orschellet al.,“Cord blood stem and progenitor cells,”
  57. (2000). osle r ,J .E .Brand t ,J .C hu t e ,andR .H offman,“An invivo competitive repopulation assay for various sources of human hematopoietic stem cells,”
  58. (1993). P a l s s o n ,S .H .P a e k ,R .M .S c h w a r t ze ta l . ,“ E x p a n s i o n of human bone marrow progenitor cells in a high cell density continuous perfusion system,”
  59. (1992). Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes,”
  60. (1996). Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients,” The New England
  61. (1995). Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replating potential: requirement for cell-to-cell interactions and colony-stimulating factors,”
  62. (1993). Preclinical analysis of cytokine therapy in the SCID-hu mouse,”
  63. (1988). Purification and characterization of mouse hematopoietic stem cells,”
  64. (1999). r i s a ,V .C i r u l l i ,K .A .S m i t h ,M .H .E l l i s m a n ,B .E .T o r b e t t
  65. (1992). Rhodamine123 reveals heterogeneity within murine Lin −,S c a - 1 + hemopoietic stem cells,”
  66. (1999). S t o r m s ,A .P .T r u j i l l o ,J .B .S p r i n g e re ta l . ,“ I s o l a t i o no f primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity,”
  67. (1990). Schlaffe r ,J .E .R u s s o ,O .M .C o l v i n
  68. (2001). Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies,”
  69. (1957). T h o m a s ,H .L .L o c h t eJ r . ,W .C .L u ,a n dJ .W .F e r r e b e e , “Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy,” The New England
  70. (1996). The effects of Flk-2/flt3 ligand as compared with c-kit ligand on shortterm and long-term proliferation of CD34+ hematopoietic progenitors elicited from human fetal liver, umbilical cord blood,bonemarrow,andmobilizedperipheralblood,”Journal of Hematotherapy,
  71. (1998). The role of c-Mpl ligands in the expansion of cord blood hematopoietic progenitors,”
  72. (1997). Thrombopoietin augments ex vivo expansion of human cord blood-derived heamatopoietic progenitors in combination with stem cell factor and
  73. (1980). Types of colonies formed by normal human bone marrow, peripheral blood and umbilical cordbloodCFUc,” Experimental Hematology,vol.8,no.10,pp .
  74. (1998). u b i n s t e i n ,C .C a r r i e r ,A .S c a r a d a v o ue ta l . ,“ O u t c o m e s among 562 recipients of placental-blood transplants from unrelated donors,” The New England
  75. (2003). Unrelated umbilical cord blood transplants in adults: early recovery of neutrophils by supportive co-transplantationof a lownumber of highlypurified peripheral blood CD34+ cells from an HLAhaploidentical donor,” Experimental Hematology,
  76. (1996). W a g n e r ,J .R o s e n t h a l ,R .S w e e t m a ne ta l . ,“ S u c c e s s -ful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft- versus-host disease,” Blood,v o l .